PHARMACOECONOMIC ANALYSIS OF RESLIZUMAB USE IN SEVERE ATOPIC ASTHMA WITH EOSINOPHILIA

被引：0
|
作者：
Kolbin, A. [1 ]
Gomon, J. [2 ]
Balykina, Y. [3 ]
Proskurin, M. [4 ]
机构：
[1] First Pavlov State Med Univ St Petersburg, St Petersburg, Russia
[2] Pavlov Med Univ, St Petersburg, Russia
[3] St Petersburg State Univ, St Petersburg, Spe, Russia
[4] St Petersburg State Univ, Moscow, Russia
来源：
VALUE IN HEALTH | 2019年 / 22卷
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PRS12
引用
收藏
页码：S874 / S874
页数：1
相关论文
共 50 条
  • [21] Pharmacoeconomic analysis of use of a simbicort turbuhaler and seretide multidisk of asthma patients
    Kulikov, A.
    Lomakin, A.
    Krysanov, I
    Polivanov, V
    VALUE IN HEALTH, 2006, 9 (06) : A333 - A333
  • [22] In patients with severe asthma with eosinophilia in reslizumab clinical trials, high peripheral blood eosinophil levels are associated with low FEV1 reversibility
    Virchow, J. Christian
    Hickey, Lisa
    Du, Evelyn
    Garin, Margaret
    ALLERGY ASTHMA AND CLINICAL IMMUNOLOGY, 2020, 16 (01):
  • [23] In patients with severe asthma with eosinophilia in reslizumab clinical trials, high peripheral blood eosinophil levels are associated with low FEV1 reversibility
    J. Christian Virchow
    Lisa Hickey
    Evelyn Du
    Margaret Garin
    Allergy, Asthma & Clinical Immunology, 16
  • [24] Pharmacoeconomic analysis of a new concept for symbicort use in bronchial asthma patients
    Campbell, J. D.
    Blough, D. K.
    Sullivan, S. D.
    VALUE IN HEALTH, 2007, 10 (06) : A404 - A404
  • [25] Compassionate Use of Reslizumab in a Life-threatening Asthma Exacerbation
    Granda, P.
    Villamanan, E.
    Heinz, S.
    Laorden, D.
    Romero, D.
    Anon, J. m
    Carpio, C.
    Sobrino, C.
    Collada, V
    Dominguez-Ortega, J.
    Herrero, A.
    Quirce, S.
    alvarez-Sala, R.
    JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY, 2024, 34 (01) : 60 - 61
  • [26] RESLIZUMAB IMPROVES SPIROMETRIC LUNG AGE IN PATIENTS WITH SEVERE EOSINOPHILIC ASTHMA
    Carr, W.
    McDonald, M.
    Meizlik, P.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2017, 119 (05) : S57 - S57
  • [27] RESPONSE TO RESLIZUMAB IN SEVERE ASTHMA PATIENTS UNRESPONSIVE TO MEPOLIZUMAB OR WITH SUSPECTED VASCULITIS
    Hama, B.
    Thomas, N.
    Elsey, L.
    Hince, K.
    Waye, R.
    Allen, D.
    Holmes, L.
    Pantin, T.
    Tavernier, G.
    Fowler, S.
    Niven, R.
    THORAX, 2019, 74 : A140 - A140
  • [28] The effectiveness of Reslizumab in severe asthma treatment: a real-world experience
    Ibrahim, H.
    O'Sullivan, R.
    Casey, D.
    Murphy, J.
    MacSharry, J.
    Plant, B. J.
    Murphy, D. M.
    RESPIRATORY RESEARCH, 2019, 20 (01)
  • [29] Reslizumab Treatment for Moderate to Severe Asthma with Elevated Blood Eosinophil Levels
    Castro, Mario
    Zangrilli, James
    Wechsler, Michael E.
    Bateman, Eric Donn
    Brusselle, Guy
    Bardin, Philip G.
    Murphy, Kevin R.
    Maspero, Jorge F.
    O'Brien, Christopher
    Korn, Stephanie
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2015, 135 (02) : AB381 - AB381
  • [30] The effectiveness of Reslizumab in severe asthma treatment: a real-world experience
    H. Ibrahim
    R. O’Sullivan
    D. Casey
    J. Murphy
    J. MacSharry
    B. J. Plant
    D. M. Murphy
    Respiratory Research, 20
12345